Share

October 24, 2006; 67 (8) Editorials

Treating MNGIE

Is reducing blood nucleosides the first cure for a mitochondrial disorder?

Patrick F. Chinnery, John Vissing
First published October 23, 2006, DOI: https://doi.org/10.1212/01.wnl.0000244751.08947.ee
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
352

Share

Article Information

vol. 67 no. 8 1330-1332
DOI: 
https://doi.org/10.1212/01.wnl.0000244751.08947.ee
PubMed: 
17060555
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 23, 2006.
Copyright & Usage: 
© 2006

Author Disclosures

    1. Patrick F. Chinnery, PhD, FRCP and
    2. John Vissing, MD, PhD
  1. Patrick F. Chinnery, PhD, FRCP and
  2. John Vissing, MD, PhD
  1. From Mitochondrial Research Group (P.F.C.), Department of Neurology, and Institute of Human Genetics, Newcastle University, UK; and Neuromuscular Research Unit and Department of Neurology (J.V.), National University Hospital, Rigshospitalet, Copenhagen, Denmark.
  1. Address correspondence and reprint requests to Prof Chinnery, M4014, The Medical School, Framlinton Place, Newcastle upon Tyne, NE2 4HH, UK; e-mail: P.F.Chinnery{at}ncl.ac.uk
View Full Text

Article usage

Article usage: October 2006 to July 2022

AbstractFullPdfSource
Oct 2006010875Highwire
Nov 200607049Highwire
Dec 200601014Highwire
Jan 200701513Highwire
Feb 200701818Highwire
Mar 200702214Highwire
Apr 20070610Highwire
May 2007099Highwire
Jun 2007055Highwire
Jul 2007011Highwire
Aug 2007043Highwire
Sep 2007011Highwire
Oct 2007074Highwire
Nov 2007012Highwire
Dec 2007056Highwire
Jan 2008066Highwire
Feb 2008010Highwire
Mar 2008011Highwire
Apr 2008033Highwire
May 2008031Highwire
Jun 2008041Highwire
Aug 2008022Highwire
Sep 2008022Highwire
Oct 2008011Highwire
Nov 2008045Highwire
Dec 2008001Highwire
Jan 2009001Highwire
Feb 2009053Highwire
Mar 2009022Highwire
Apr 2009002Highwire
Jun 2009020Highwire
Jul 2009042Highwire
Aug 2009031Highwire
Sep 2009042Highwire
Oct 2009063Highwire
Nov 2009010Highwire
Dec 2009031Highwire
Jan 2010011Highwire
Feb 2010042Highwire
Mar 2010011Highwire
Apr 2010033Highwire
May 2010012Highwire
Jun 2010022Highwire
Jul 2010054Highwire
Aug 2010010Highwire
Nov 2010011Highwire
Dec 2010091Highwire
Jan 2011072Highwire
Feb 2011020Highwire
Mar 2011081Highwire
Apr 2011063Highwire
Sep 2011041Highwire
Oct 2011310Highwire
Nov 20111200Highwire
Dec 2011301Highwire
Jan 20121611Highwire
Feb 20122940Highwire
Mar 20121821Highwire
Apr 20123031Highwire
May 20123311Highwire
Jun 20122701Highwire
Jul 20123310Highwire
Aug 20122301Highwire
Sep 20121110Highwire
Oct 2012911Highwire
Jun 20131900Highwire
Jul 2013200Highwire
Aug 2013300Highwire
Sep 2013500Highwire
Oct 20131100Highwire
Nov 20131400Highwire
Dec 20131300Highwire
Jan 20141301Highwire
Feb 2014200Highwire
Mar 2014700Highwire
Apr 2014710Highwire
May 2014200Highwire
Jun 2014501Highwire
Jul 2014400Highwire
Aug 2014400Highwire
Sep 2014800Highwire
Oct 2014523Highwire
Nov 2014100Highwire
Dec 20141000Highwire
Jan 2015611Highwire
Feb 2015300Highwire
Mar 20151100Highwire
Apr 20151211Highwire
May 2015500Highwire
Jun 2015002Highwire
Jul 2015200Highwire
Aug 2015710Highwire
Sep 2015100Highwire
Oct 2015100Highwire
Nov 2015300Highwire
Dec 2015400Highwire
Jan 2016611Highwire
Feb 20161010Highwire
Mar 2016600Highwire
Apr 20161200Highwire
May 2016700Highwire
Jun 2016900Highwire
Jul 2016310Highwire
Aug 2016700Highwire
Sep 20161200Highwire
Oct 20161300Highwire
Nov 20161200Highwire
Dec 2016500Highwire
Jan 2017400Highwire
Feb 2017700Highwire
Mar 2017800Highwire
Apr 20171010Highwire
May 2017500Highwire
Jun 2017901Highwire
Jul 2017600Highwire
Aug 2017300Highwire
Sep 2017900Highwire
Oct 2017800Highwire
Nov 2017200Highwire
Dec 2017902Highwire
Jan 20181000Highwire
Feb 2018710Highwire
Mar 20182310Highwire
Apr 2018401Highwire
May 20181700Highwire
Jun 20181501Highwire
Jul 2018700Highwire
Aug 2018900Highwire
Sep 20181001Highwire
Oct 20181300Highwire
Nov 2018600Highwire
Dec 2018500Highwire
Jan 20191010Highwire
Feb 2019600Highwire
Mar 2019700Highwire
Apr 20193002Highwire
May 20191000Highwire
Jun 20191301Highwire
Jul 20192002Highwire
Aug 20191200Highwire
Sep 20191111Highwire
Oct 20191801Highwire
Nov 20191803Highwire
Dec 20191001Highwire
Jan 20201104Highwire
Feb 20202216Highwire
Mar 20201803Highwire
Apr 20201000Highwire
May 20201001Highwire
Jun 2020800Highwire
Jul 2020501Highwire
Aug 20201310Highwire
Sep 20201303Highwire
Oct 2020901Highwire
Nov 20201110Highwire
Dec 20201602Highwire
Jan 20211512Highwire
Feb 20211001Highwire
Mar 20211501Highwire
Apr 20211800Highwire
May 2021600Highwire
Jun 2021600Highwire
Jul 2021800Highwire
Aug 2021400Highwire
Sep 2021400Highwire
Oct 2021600Highwire
Nov 20211000Highwire
Dec 2021800Highwire
Jan 2022501Highwire
Feb 20221100Highwire
Mar 2022400Highwire
Apr 20221100Highwire
May 2022600Highwire
Jun 2022500Highwire
Jul 2022123Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

  • Treating MNGIE
    • Shamima Rahman, University College London Institute of Child Health, Mitochondrial Research Group, Clinical and Molecular Genetics Unit, University College London Insti
    • Iain P Hargreaves
    Submitted February 01, 2007
  • Reply from the authors
    • Michio Hirano, Columbia University Medical Center, 630 West 168th Street, P&S 4-443, New York, NY 10032
    • Ramon A. Martí, and Salvatore DiMauro
    Submitted February 01, 2007
  • Reply from the editorialists
    • Patrick F. Chinnery, Mitochondrial Research Group and Institute of Human Genetics, Newcastle Univeristy, M4014, The Medical School, Framlinton Place, Newcastle upon Tyne, NE2 4HH, UK
    • John Vissing
    Submitted February 01, 2007
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me